Last updated: April 29, 2024
Sponsor: Riphah International University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetic Neuropathy
Diabetes Mellitus Types I And Ii
Neurologic Disorders
Treatment
Neural Flossing
Propioceptive Neuromascular facilitation
Clinical Study ID
NCT06397209
REC/RCR&AHS/23/0275
Ages 45-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Clinically Diagnosed with type I and II diabetes
- Patients 45 to 65 years of age
- The participants who scored <3 as per the Michigan Neuropathy Screening Instrument (MNSI) were included in the study.
- Able to stand and walk without assistance
Exclusion
Exclusion Criteria:
- Patients have other neurological or orthopedic impairments (such as stroke,cerebralpalsy, poliomyelitis, rheumatoid arthritis, prosthesis, or moderate or severeosteoarthritis)
- Major vascular complications (venous or arterial ulcers).
- Severe retinopathy
- Severe nephropathy that causes edema or requires haemodialysis
Study Design
Total Participants: 50
Treatment Group(s): 2
Primary Treatment: Neural Flossing
Phase:
Study Start date:
December 23, 2023
Estimated Completion Date:
October 01, 2024
Study Description
Connect with a study center
Dhillon Surgical Hospital
Burewala, Punjab 61010
PakistanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.